Last SFr.97.45 CHF
Change Today -0.70 / -0.71%
Volume 7.1M
NOVN On Other Exchanges
New York
SIX Swiss Ex
SIX Swiss Ex
As of 11:43 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Hans-Ulrich Doerig Ph.D.

Former Director, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 7 different industries.



Dr. Hans-Ulrich Doerig, Ph.D. served as the President of Executive Board of Credit Suisse Group AG since 1996 and also served as its Chief Risk Officer from 1998 to 2002 and Vice Chairman of the Group Executive Board from 1998 to 2003. Dr. Doerig served as Chief Executive Officer of Credit Suisse First Boston since 1997. He served as a Member of the Executive Board of Credit Suisse since 1982 and was responsible for the multinational division, securities trading, capital ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056


Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

Former Chairman of The Board
Former Director
Former Director
Former Director
Former Vice Chairman, Chairman of Risk Committee and Member of Chairman’s and Governance Committee
Former Vice Chairman, Chairman of Risk Committee and Member of Chairmans & Governance Committee
Former Director


Unknown/Other Education
Universität St. Gallen
Universität St. Gallen
Doctorate 1968
Universität St. Gallen

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVN:VX SFr.97.45 CHF -0.70


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at